RAYE:NYE-Rayliant Quantamental Emerging Market Equity ETF (USD)

ETF | Others |

Last Closing

USD 26.96

Change

0.00 (0.00)%

Market Cap

USD 0.06B

Volume

2.12K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies in emerging markets, excluding China. The Adviser considers a company to be an emerging market company if it is organized or maintains its principal place of business in an emerging market country. The equity securities in which the it invests are primarily common stocks and depositary receipts, including unsponsored depositary receipts, but may also include preferred stock and securities of other investment companies.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing RAYE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.47% 78% C+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.47% 78% C+ 74% C
Trailing 12 Months  
Capital Gain 27.74% 76% C+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.74% 76% C+ 72% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.53% N/A N/A 51% F
Dividend Return 4.00% N/A N/A 44% F
Total Return 0.47% N/A N/A 12% F
Risk Return Profile  
Volatility (Standard Deviation) 13.38% N/A N/A 69% C-
Risk Adjusted Return 29.93% N/A N/A 47% F
Market Capitalization 0.06B 51% F 20% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike